1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market is demonstrating dynamic change due to evolving biologic development, sophisticated manufacturing technologies, and shifting global supply chain frameworks. Senior decision-makers in pharmaceuticals and biotechnology must navigate an increasingly complex landscape involving regulatory standards, personalized therapies, and global trade policies impacting access and growth.
Market Snapshot: GM-CSF Market Landscape
The GM-CSF market is positioned for substantial growth, supported by innovation in protein engineering, recombinant DNA capabilities, and regulatory advancements validating both novel and biosimilar therapies. Stakeholders benefit from a climate that encourages expedited pathways for product approvals, upgraded stability and efficacy in formulations, and improved global healthcare access.
Scope & Segmentation
This report delivers in-depth segmentation and market forecasting, enabling senior executives to better understand critical opportunity areas:
- Product Type: Biosimilars (approved, in development), Recombinant GM-CSF (approved, in development)
- Application Areas: Acute Myeloid Leukemia (approved, in development), Chemotherapy-Induced Neutropenia (approved, in development), Chronic Myelogenous Leukemia (approved, in development)
- Route of Administration: Intravenous, Subcutaneous
- End User Segments: Home Care Settings, Hospitals, Research Institutions, Specialty Clinics
- Dosage Forms: Liquid solutions (approved, in development), Lyophilized powders (approved, in development)
- Distribution Channel: Hospital pharmacies, Online pharmacies, Retail pharmacies
- Geographic Coverage: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Featured Companies: Partner Therapeutics, Inc., Teva Pharmaceuticals Europe B.V., Ferring Pharmaceuticals S.A., Zenyaku Kogyo Co., Ltd., Samyang Biopharm Co., Ltd., Landos Biopharma, Inc.
Key Takeaways for Decision-Makers
- Technological progress in continuous bioprocessing and real-time analytical monitoring is reducing variability and supporting more robust supply chains.
- Regulatory flexibility for biosimilars and novel GM-CSF analogues drives increased competition and enhances patient access to essential hematopoietic therapies.
- Collaborations between pharmaceutical innovators, contract manufacturing partners, and academic institutions foster efficient pipeline progression and diverse formulation initiatives.
- Patient-centered approaches, including biomarker-driven dosing and new delivery formats, create pathways for more personalized care and improved outcomes.
- Strategic investment in regional manufacturing and diversification of supplier relationships helps companies adapt to changing tariff and global trade dynamics.
Tariff Impact: Navigating 2025 Biologic Supply Chain Shifts
The 2025 United States tariff policies have prompted reconfiguration of global GM-CSF supply networks, affecting imported culture media and single-use assemblies with higher duties. Companies are adopting supply chain risk mitigation such as increasing domestic sourcing, revising cost structures, and building local strategic alliances. These actions support margin preservation and maintain steady product availability despite trade-induced uncertainties.
Methodology & Data Sources
This research is grounded in comprehensive secondary analysis from peer-reviewed literature, regulatory filings, clinical trial registries, and public company disclosures. In-depth interviews with medical and manufacturing experts, combined with analytical frameworks including SWOT and Porter’s Five Forces, ensure accuracy and actionable insights.
Why This Report Matters
- Uncovers actionable strategies to enhance resilience and seize new market opportunities within the GM-CSF ecosystem.
- Empowers leadership to proactively manage regulatory, technological, and supply chain risks while tailoring solutions to regional needs.
- Supports informed investment and product development decisions by providing detailed segmentation and competitive analysis.
Conclusion
GM-CSF market trends highlight significant potential for innovation-driven growth, global access improvements, and competitive realignment. This report equips senior leaders with the clarity required to guide winning strategies in an evolving therapeutic landscape.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging biosimilar GM-CSF products reshaping cost dynamics and market access for supportive oncology care
5.2. Increasing off-label use of GM-CSF in COVID-19 and viral pneumonia management influencing research pipelines
5.3. Advancements in single-use bioreactor technology intensifying GM-CSF manufacturing efficiency and scalability
5.4. Strategic licensing agreements between biotech firms expanding regional GM-CSF distribution in Asia-Pacific markets
5.5. Development of inhaled GM-CSF therapies unlocking novel treatment pathways for pulmonary alveolar proteinosis
5.6. Integration of GM-CSF with immuno-oncology regimens to enhance tumor microenvironment modulation
5.7. Patent expirations opening competitive landscape for next-generation GM-CSF formulations and combination drugs
5.2. Increasing off-label use of GM-CSF in COVID-19 and viral pneumonia management influencing research pipelines
5.3. Advancements in single-use bioreactor technology intensifying GM-CSF manufacturing efficiency and scalability
5.4. Strategic licensing agreements between biotech firms expanding regional GM-CSF distribution in Asia-Pacific markets
5.5. Development of inhaled GM-CSF therapies unlocking novel treatment pathways for pulmonary alveolar proteinosis
5.6. Integration of GM-CSF with immuno-oncology regimens to enhance tumor microenvironment modulation
5.7. Patent expirations opening competitive landscape for next-generation GM-CSF formulations and combination drugs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Granulocyte Macrophage Colony Stimulating Factor Market, by Product
8.1. Introduction
8.2. Biosimilar
8.2.1. Approved
8.2.2. In Development
8.3. Recombinant
8.3.1. Approved
8.3.2. In Development
8.2. Biosimilar
8.2.1. Approved
8.2.2. In Development
8.3. Recombinant
8.3.1. Approved
8.3.2. In Development
9. Granulocyte Macrophage Colony Stimulating Factor Market, by Application
9.1. Introduction
9.2. Acute Myeloid Leukemia
9.2.1. Approved
9.2.2. In Development
9.3. Chemotherapy Induced Neutropenia
9.3.1. Approved
9.3.2. In Development
9.4. Chronic Myelogenous Leukemia
9.4.1. Approved
9.4.2. In Development
9.2. Acute Myeloid Leukemia
9.2.1. Approved
9.2.2. In Development
9.3. Chemotherapy Induced Neutropenia
9.3.1. Approved
9.3.2. In Development
9.4. Chronic Myelogenous Leukemia
9.4.1. Approved
9.4.2. In Development
10. Granulocyte Macrophage Colony Stimulating Factor Market, by Route
10.1. Introduction
10.2. Intravenous
10.3. Subcutaneous
10.2. Intravenous
10.3. Subcutaneous
11. Granulocyte Macrophage Colony Stimulating Factor Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Research Institutions
11.5. Specialty Clinics
11.2. Home Care Settings
11.3. Hospitals
11.4. Research Institutions
11.5. Specialty Clinics
12. Granulocyte Macrophage Colony Stimulating Factor Market, by Dosage Form
12.1. Introduction
12.2. Liquid Solution
12.2.1. Approved
12.2.2. In Development
12.3. Lyophilized Powder
12.3.1. Approved
12.3.2. In Development
12.2. Liquid Solution
12.2.1. Approved
12.2.2. In Development
12.3. Lyophilized Powder
12.3.1. Approved
12.3.2. In Development
13. Granulocyte Macrophage Colony Stimulating Factor Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
14. Americas Granulocyte Macrophage Colony Stimulating Factor Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Partner Therapeutics, Inc.
17.3.2. Teva Pharmaceuticals Europe B.V.
17.3.3. Ferring Pharmaceuticals S.A.
17.3.4. Zenyaku Kogyo Co., Ltd.
17.3.5. Samyang Biopharm Co., Ltd.
17.3.6. Landos Biopharma, Inc.
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Partner Therapeutics, Inc.
17.3.2. Teva Pharmaceuticals Europe B.V.
17.3.3. Ferring Pharmaceuticals S.A.
17.3.4. Zenyaku Kogyo Co., Ltd.
17.3.5. Samyang Biopharm Co., Ltd.
17.3.6. Landos Biopharma, Inc.
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHAI
FIGURE 28. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHSTATISTICS
FIGURE 29. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHCONTACTS
FIGURE 30. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHAI
FIGURE 28. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHSTATISTICS
FIGURE 29. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHCONTACTS
FIGURE 30. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 154. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 155. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 156. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 157. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 160. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 161. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 162. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 163. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 164. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 165. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 166. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 167. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 172. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 173. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 174. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 175. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 178. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 179. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 180. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 181. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 182. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 183. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 186. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 187. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 188. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 189. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 198. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 199. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AF
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPROVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY IN DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 154. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 155. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 156. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 157. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 160. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 161. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 162. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 163. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 164. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 165. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 166. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 167. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 172. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 173. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 174. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 175. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. CANADA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 178. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 179. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 180. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 181. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 182. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 183. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 186. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 187. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 188. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 189. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 198. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 199. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. MEXICO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHEMOTHERAPY INDUCED NEUTROPENIA, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY CHRONIC MYELOGENOUS LEUKEMIA, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LIQUID SOLUTION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR MARKET SIZE, BY BIOSIMILAR, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AF
Samples
LOADING...
Companies Mentioned
The companies profiled in this Granulocyte Macrophage Colony Stimulating Factor market report include:- Partner Therapeutics, Inc.
- Teva Pharmaceuticals Europe B.V.
- Ferring Pharmaceuticals S.A.
- Zenyaku Kogyo Co., Ltd.
- Samyang Biopharm Co., Ltd.
- Landos Biopharma, Inc.
